Determination of the enantiomers of thioridazine, thioridazine 2-sulfone, and of the isomeric pairs of thioridazine 2-sulfoxide and thioridazine 5-sulfoxide in human plasma
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
The genetic polymorphism of debrisoquine/sparteine metabolism — Clinical aspects
1990 • 367 citations
Clinical significance of the sparteine/debrisoquine oxidation polymorphism
1989 • 292 citations
Plasma levels of thioridazine and metabolites are influenced by the debrisoquin hydroxylation phenotype
1991 • 162 citations
Active Metabolites of Neuroleptic Drugs
1982 • 76 citations
Receptor affinity, neurochemistry and behavioral characteristics of the enantiomers of thioridazine: Evidence for different stereoselectivities at D1 and D2 receptors in rat brain
1988 • 45 citations
Determination of Thioridazine Enantiomers in Human Serum by Sequential Achiral and Chiral High-Performance Liquid Chromatography
1993 • 32 citations
Thioridazine toxicity--an experimental cardiovascular study of thioridazine and its major metabolites in overdose.
1985 • 24 citations
Synthesis, Isolation, and Characterization of Two Stereoisomeric Ring Sulfoxides of Thioridazine
1983 • 24 citations
Artifacts in the analysis of thioridazine and other neuroleptics
1993 • 20 citations
Greater potency of mesoridazine and sulforidazine compared with the parent compound, thioridazine, on striatal dopamine autoreceptors.
1984 • 19 citations
Plasma Levels of Trimipramine and Metabolites in Four Patients
1992 • 18 citations
Light-Induced Racemization
1991 • 17 citations
Relative configuration of thioridazine enantiomers
1991 • 14 citations
High-performance liquid chromatographic resolution of the enantiomers of thioridazine, its metabolites and related compounds
1988 • 13 citations
Comparative antidopaminergic properties of thioridazine, mesoridazine and sulforidazine on the corpus striatum.
1989 • 12 citations
Cited By (0)
No citing papers found in database